Share on StockTwits

Fluidigm (NASDAQ:FLDM) CFO Vikram Jog unloaded 5,427 shares of Fluidigm stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $30.61, for a total transaction of $166,120.47. Following the sale, the chief financial officer now directly owns 290 shares in the company, valued at approximately $8,877. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

FLDM has been the subject of a number of recent research reports. Analysts at Piper Jaffray reiterated an “overweight” rating on shares of Fluidigm in a research note on Tuesday, May 6th. They now have a $50.00 price target on the stock, down previously from $51.00. Separately, analysts at Maxim Group cut their price target on shares of Fluidigm from $65.00 to $52.00 in a research note on Tuesday, May 6th. They now have a “buy” rating on the stock. Finally, analysts at Leerink Swann cut their price target on shares of Fluidigm from $52.00 to $48.00 in a research note on Tuesday, May 6th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $44.76.

Shares of Fluidigm (NASDAQ:FLDM) traded down 1.46% on Wednesday, hitting $29.61. The stock had a trading volume of 316,884 shares. Fluidigm has a 52-week low of $16.23 and a 52-week high of $49.46. The stock has a 50-day moving average of $28.54 and a 200-day moving average of $37.62. The company’s market cap is $830.9 million.

Fluidigm (NASDAQ:FLDM) last released its earnings data on Monday, May 5th. The company reported ($0.57) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.31) by $0.26. The company had revenue of $25.70 million for the quarter, compared to the consensus estimate of $22.91 million. The company’s quarterly revenue was up 77.2% on a year-over-year basis. Analysts expect that Fluidigm will post $-1.71 EPS for the current fiscal year.

Fluidigm Corporation (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.